Trial Profile
Mitigating the Mitochondrial Dysfunction and Apoptosis in Hypertrophied Left Atrium of Patients With Severe Mitral Valve Regurgitation Via Short-term Lovaza Treatment Prior to Surgery.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Mitral valve disorders
- Focus Pharmacodynamics
- 09 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Jun 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 19 Jan 2010 New trial record